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Abstract 
Objectives: This study aimed to explore the effect of antidepressant treatment on the HPA axis, changes in depression score, and serum levels of TNF-α in 
depressed infertile women. Methods: In this randomized controlled trial research, 60 infertile women who had undergone in vitro fertilization (IVF) treatment 
with depression scores between 16-47 were divided into two groups. The intervention group with fluoxetine capsule was under treatment for two months before 
the embryo transfer, while the control group was given placebo. Depression score, serum levels of tumor necrosis factor alpha (TNF-α) as well as cortisol hor-
mone levels were measured and recorded both before and after the intervention. The data were analyzed using SPSS version 21 software. Results: We analyzed 
the data related to 55 subjects who had undergone embryo transfer. 7 subjects in the intervention group and 3 in the control group got pregnant. We observed 
a significant decrease in the depression score (p < 0/001) and serum levels of cortisol (p = 0/001) in the intervention group. There was a significant increase in 
the serum levels of TNF-α in the intervention group (p < 0/001). There was a significant difference between the two groups in the number of pregnancies (p = 
0.04). However, there was no statistical difference between them with regard to the number of harvested oocytes (p = 0.174). Discussion: Decrease in depression 
score and cortisol level, and an increase in the levels of TNF-α in the intervention group caused any changes in the number of oocytes in comparison with the 
control group. However, the number of pregnancies was larger in the intervention group. 
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Introduction
Cytokines are small proteins that are released through white 
blood cells, especially macrophages or some tissues in response to 
stimulants1. Some cytokines such as interferon and tumor necrosis 
factor alpha (TNF-α) are of cytotoxic effects, while some of them 
like growth factors have no cytotoxic effect. Some others have a 
prominent role in reproduction, gonadal function, implantation, and 
miscarriage2. TNF-α factor is one of the cytokines that has certain 
anti-inflammatory effects and is evaluated as a necessary index 
in many inflammatory diseases to assess the patients’ responses 
to treatment. There is a relationship between an increase in the 
production of this cytokine and a variety of diseases like rheumatoid 
arthritis, atherosclerosis, diabetes, obesity, etc.3. Depression is 
thought of as another disorder that causes an increase in TNF-α and 
the number of cytokines in a person. On the one hand, depression 
leads to the production of inflammatory cytokines by activating the 
immune system. However, the patient’s immunes system is influenced 
by simultaneous activation of HPA axis4. An increase in the level of 
inflammatory cytokines in depressed people will cause disorders 
in the brain function which will ultimately lead to activation of the 
hypothalamus-pituitary-adrenal axis (HPA)5-7. Cortisol is released as 
a result of activation of this axis and this biomarker affects pregnancy 
establishment and egg quality just as TNF-α does8-11. It is because 
cortisol has a series of safety properties that can affect immunological 
conditions for implantation. In a study carried out in 2011 on 264 
depressed infertile women undergoing IVF treatment, cortisol and 
norepinephrine hormones were measured in women’s serum and 
follicular fluid. Higher pregnancy rates were reported in women 
with lower cortisol and norepinephrine levels12. According to Arslan’s 
study, on the effect of TNF-α on pregnancy, TNF-α was significantly 
high in 60% (12 out of 20) of the women who had suffered from 
recurrent miscarriages; this shows the effect of this cytokine on the 
egg quality and lack of suitable implantation for the embryo9.
For many reasons, infertility has created a stressful situation with 
a lot of pain and suffering which leads to depression. It has been 
reported that prevalence of depression symptoms among infertile 
women is twice as much as that in fertile women13. Prevalence of 
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depression and anxiety is high in women undergoing infertility 
treatment. 11 percent of these women suffer from major depression 
and 15 percent of them suffer from anxiety disorders14. As mentioned 
before, depression will cause disorders in the immune system and 
will, therefore, affect the chances of pregnancy. Thus, treating 
depression could help this group of women. Today, selective serotonin 
reuptake inhibitors (SSRI) such as fluoxetine are known as the most 
commonly used antidepressants among women of childbearing age 
and even pregnant women. The reason why these drugs are highly 
used is their appropriate therapeutic effect and very few side effects15. 
However, the effect of SSRIs on fertility and the ability to get pregnant 
has not been clearly specified13. According to the above mentioned 
points, Fluoxetine was used for depression treatment in this study, so 
that we could analyze its effect on the serum level of TNF-α, changes 
in the HPA axis and the level of depression in people and determine 
the potential effect of these 3 factors on the patients’ pregnancy. 
Methods
Patients and intervention
The present study was a randomized controlled trial research which 
investigated the effect of Fluoxetine anti-depressant in women 
suffering from depression as well as its effect on depression score, 
serum levels of TNF-α and its subsequent changes in the function of 
HPA axis and finally fertility rate after IVF. This study was done from 
March 2014 to February 2016 in the clinic of infertility treatment 
at Shiraz University of Medical Sciences and obtained the approval 
of the Ethics Committee of Shiraz University of Medical Sciences 
(cod: CT-P9370-7870). The patients having undergone IVF filled out 
Beck Depression Inventory (BDI) and those with depression scores 
between 16 and 47 were sampled and studied provided that they met 
the inclusion criteria. Then, they were examined by a psychiatrist 
who prescribed 20 milligrams of Fluoxetine every day for two 
months. All the patients had a complete physical examination, and 
were asked about their medical history; all the tests were analyzed, 
and demographic questionnaire was filled out by all of them. All 
the patients were informed of the methodology and the possible 
side effects and filled out a written consent. Inclusion criteria were 
as follows: 1. undergoing the first IVF; 2. not suffering from chronic 
diseases, esp. infectious diseases, endocrine diseases and cancer; 3. 
not being under medical treatment and not having undergone mental 
health counseling; and 4. having no history of drug abuse. 
Exclusion criteria of the study were as follows: 1. patient’s lack 
of willingness to continue cooperation; 2. suffering from the side 
effects of Fluoxetine; and 3. treatment cancellation. The number 
of samples was determined by a statistical consultant based on the 
expected reduction in the depression score after the intervention 
and also according to similar studies conducted by Hubertus 
Himmerich (2006) and Tuglu (2003)16,17. After calculating a 10 
percent potential loss, in each group 30 women and altogether 60 
infertile women suffering from depression were selected based on 
purpose-oriented approach. After sample size calculation, permuted 
block randomization was used to assign patients into two groups; A: 
treatment with Fluoxetine capsule, B: control group using placebo. 
We assigned the patients into two groups in a 1:1 ratio. Then, 15 
blocks of 4 (example AABB...) were prepared, and the patients were 
consecutively assigned to the blocks until the sample size in each 
group was completed (Figure 1). Fluoxetine and placebo capsules were 
prescribed according to the specific code, so that the patient himself, 
the physician, the operating room personnel, and the IVF personnel 
ward did not know which group the patient belonged to. All patients 
began daily HMG injections on day 2 of the menstrual cycle and were 
referred again on day 6 for ultrasound and serum estradiol levels. HCG 
injection and subsequent oocyte retrieval were performed only in 
patients with more than 4 follicles over 17 mm in their ovaries. About 
36 hours after hCG injection, oocyte retrieval was performed. At the 
same time, the sperm sample of the patient’s husband was taken in 
the morning and processed in the laboratory and then fertilized with 
the egg in the designated culture medium. The embryos were then 
frozen for transfer to the next cycle by vitrification method. Ovarian 
stimulation, uterine preparation, and embryo transfer were performed 
Figure 1. CONSORT flow diagram for sampling.
Enrollment
Allocation & 
Intervention 
(2month)
Analysis
Follow-Up
After embryo 
transmission
(About 3 weeks)
Assessed for eligibility (n = 80)
Randomized (n = 60)
Excluded (n = 20)
• Not meeting inclusion criteria (n = 12)
• Declined to participate (n = 5)
• Other reasons (n = 3)
Control:
Allocated to intervention (n = 30)
• Received allocated intervention (n = 30)
• Did not receive allocated intervention (n = 0)
• Discontinued intervention (n = 2)
2 Patient Due to Lack of embryo transmission
Lost to follow-up (n = 0)
Positive pregnancy test: 3
Analysed (n = 28)
• Excluded from analysis (n = 0)
Analysed (n = 27)
• Excluded from analysis (n = 0)
Intervention:
Allocated to intervention (n = 30)
• Received allocated intervention (n = 29)
• Did not receive allocated intervention (n = 1)
1 Patient Due to fluoxetine side effects
• Discontinued intervention (n = 2)
2 Patient Due to Lack of embryo transmission
Lost to follow-up (n = 0)
Positive pregnancy test: 7
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for all patients in the same manner. 55 patients (28 in control group 
and 27 in intervention group) were able to freeze the embryo for the 
transfer day. The researchers checked the quality of all the embryos; in 
grade A, the blastomeres were identical in size and there were no signs 
of fragmentation in them. In grade B, a number of the blastomeres 
were unequal in size and there were signs of fragmentation in 10% 
of them; Grades C and D were not transferred. Based on the embryo 
quality, the quality of all the transferable embryos were grades A or 
B and only one embryo was transferred.
The uterine preparation was done in the next cycle. The patient was 
taking 6 mg daily of estradiol pills from the second day of menstruation 
(2 mg estradiol pills Aburaihan Pharmacy Co., Tehran, Iran-three 
pills a day), to prepare their endometrium for transfer; on the 9th, 
10th, or 11th days after the beginning of menstruation, the thickness 
of the endometrium in each patient was measured using transvaginal 
sonography. If the thickness of the uterine wall was more than 8 mm, 
the patient was administered an intramuscular injection of 100mg 
progesterone (50 mg progesterone ampules Aburaihan Pharmacy 
Co., Tehran, Iran – 2 ampules were administered); 2 days after the 
progesterone injection, the embryo was transferred. Embryo transfer 
was carried out guided by ultrasound sonography; the catheter was 
entered into the cervix and the embryo was transferred (this method is 
called ultrasound-guidance or catheter guidance). BhCG test was done 
on the patients two or three weeks after the embryo transfer and if the 
result of the test was positive, biochemical pregnancy was confirmed. 
Data collection
The data of every individual’s depression score were recorded on 
the day of the surgery both before and after the intervention, using 
Beck Depression Inventory (BDI). Blood samples were taken for 
TNF-α serum check and cortisol simultaneously with filling out Beck 
questionnaire before and after the intervention. The first blood test 
was done in laboratory and the second one was done in the operating 
room before the embryo transfer between 8 and 9 a.m. Each time, 
5cc of blood was taken. The samples were centrifuged immediately 
and kept at -70 degrees. The obtained values were then recorded, 
using ELISA method. 
Analyzed consequences
1. Changes in TNF-α factor; 2. Changes in the depression score; 3. 
Changes in the cortisol level; 4. Positive pregnancy test (biochemical 
pregnancy rate) in the groups; and 5. The number of harvested 
oocytes in each group. The serum levels of cortisol were measured 
by ELISA using a French BioMérieux kit in the serum, and used to 
measure TNF levels using the IBL ELISA kit (Human TNF-alpha), 
which was made in Ireland.
Statistical analysis
The data related to 55 patients under the study which had been 
obtained from demographic survey and clinical variables were 
recorded at the end of the treatment and IVF process in statistical 
analysis program and the following were done based on the objectives 
of statistical analysis study. T-test was used to analyze the difference 
between demographic data in the two groups; also, chi-square test was 
used to determine the difference between the two groups with regard 
to pregnancy, and paired t-test was used to determine the changes in 
variables before and after the intervention. SPSS software was used to 
analyze the data, and the significance level was considered to be 0.05. 
Results
There were 60 participants in this study. After considering the loss 
of some participants (3 in the medicine group and 2 in the control 
group), 55 subjects remained in the study, 28 in the control group 
and 27 in the Fluoxetine group. 10 out of 55 subjects who did embryo 
transfer got pregnant (7 in the intervention group and 3 in the control 
group). Two groups in terms of demographic characteristics, third 
day hormones, and cause of infertility were not statistically significant 
before intervention and the two groups were homogeneous (Table 1).
Positive pregnancy outcome in this study was considered to be 
a positive pregnancy test. According to the results of T-test, there 
was no significant difference between the two groups in terms of 
age, BMI, duration of marriage, and duration of infertility (Table 2). 
Paired sample test was used both before and after the intervention to 
Table 1. Demographic characteristics and examination of day 3 hormones and causes of infertility
Fluoxetine (n = 27) Control (n = 28) P
Mean (SD) Mean (SD)
Age (year) 30.47 (4.54) 30.43 (5.34) 0.516
BMI (kg/m2) 25.06 (3.53) 26.61 (5.34) 0.262
Time of marriage (year) 8.08 (5.23) 8.26 (5.88) 0.916
Time of infertility (year) 5.60 (4.84) 5.82 (4.06) 0.870
FSH (third day) 6.07 (3.17) 6.31 (2.33) 0.555*
LH (third day) 4.77 (2.67) 4.69 (3.94) 0.340*
AMH (third day) 4.58 (3.68) 4.56 (3.68) 0.919*
Est (third day) 61.83 (21.07) 56.49 (37.67) 0.223*
Cause of infertility
(Percent) (Percent)
Male 39.1% 34.8%
0.182**
Female 21.7% 47.8%
Both 17.4% 13.0%
Idiopathic 21.7% 4.3%
* My Whitney Test. ** Fisher exact test.
Table 2. Demographic characteristics of the two groups (fluoxetine and controls)
Fluoxetine (n = 27) Control (n = 28) P
Mean (SD) Mean (SD)
Age (year) 30.47 (4.54) 30.43 (5.34) 0.516
BMI (kg/m2) 25.06 (3.53) 26.61 (5.34) 0.262
Time of marriage (year) 8.08 (5.23) 8.26 (5.88) 0.916
Time of infertility (year) 5.60 (4.84) 5.82 (4.06) 0.870
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analyze the changes in depression; as shown in Table 3, there was a 
significant decrease in the depression score in the intervention group. 
As can be seen in the results of Paired t-test, there was a significant 
increase in the serum levels of TNF-α in the intervention group on the 
day of transfer. Paired t-test was also used to analyze the changes in 
cortisol both before and after the intervention. The results related to 
cortisol level in these two groups showed that there was a significant 
decrease in the cortisol serum level of the Fluoxetine group (p = 
0.001). However, these changes were not observed in the control 
group (p = 0.734). 
Seven participants in the Fluoxetine group and 3 in the control 
group got pregnant. According to the results of chi-square test, there 
was a significant statistical difference in the pregnancy rate between 
the control and intervention groups (p = 0.04), and the number of 
pregnancies in the fluoxetine group was twice as many as those in 
the control group. The two groups were also compared in terms of the 
average number of harvested oocytes. According to the results of T-test, 
there was no significant statistical difference between the average 
number of oocytes in the control and intervention groups (Table 4). 
Discussion
In this study, we analyzed the level of depression in the two groups 
after taking fluoxetine (intervention group) and placebo (control 
group) for two months and noticed that there was a significant 
decrease in the depression score measured using Beck inventory in 
the intervention group. This result could lend credence to the good 
effect of SSRI on decreasing the level of depression14. With an increase 
in the prevalence of depression among women of childbearing age 
and especially infertile women, these drugs have been widely used as 
they have helped to decrease the depression score to a considerable 
extent15. In the studies done by Faramarzi in the years 2008 and 2013, 
there was a significant decrease in the infertile patients’ depression 
score as a result of the administration of Fluoxetine18,19.
In the present study, there was a significant increase in the 
levels of TNF-α after the intervention, possibly as a consequence of 
the significant decrease in serum cortisol levels in the intervention 
group, since cortisol inhibits TNF-α production. According to the 
Metaanalyses done by Dowlati and Liu in 2009 and 2011, depression 
affects the production of cytokines and increases the production of 
inflammatory factors, especially TNF-α and IL-620,21. Based on a 
study done by Shen et al. in 2010, the number of proinflammatory 
cytokines in the patients suffering from depression was significantly 
larger than those in non-depressed ones. However, after the patients 
were treated with antidepressants, there was a decrease in the level 
of these cytokines, but it was stiller larger than those in the non-
depressed subjects4. According to Liu (2011), not only does the 
administration of Fluoxetine decrease the serum levels of TNF-α, but 
also it decreases the level of its mRNA22. The difference between the 
results of this study and the other mentioned studies could be due 
to the fact that the level of inflammatory cytokines causes disorder 
in the brain function, as a result of which there will be changes in 
the function of HPA system21,23 and thus changes in the cortisol 
level. Accordingly, hypothalamus releases corticotropin releasing 
hormone (CRH) and increases the release of adrenocorticotropin 
(ACTH) from pituitary gland. As a result, cortisol is released 
from the adrenal gland16. An increase in the cortisol level leads to 
a decrease in TNF-α if there is negative feedback. Meanwhile, if 
there is a decrease in cortisol for any reason, there is an increase 
in TNF-α level once again24-26. As mentioned in the results of the 
study, there was a significant decrease in the cortisol level in the 
intervention group after the intervention, which was thought of as 
a stimulant for increasing TNF-α levels in people suffering from 
depression. In different studies, cortisol has been considered as the 
most important negative feedback signal for controlling cytokines 
and a suppressor of the production of cytokines27,28. A study done by 
Piletz in 2009 also indicated an increase in TNF-α after depression 
treatment29. In this study, venlafaxine and duloxetine were used 
and an increase in the TNF-α level in this study could be due to 
the intrinsic anti-flammatory effects of norepinephrine on the 
immune cells. Different results were reported in studies done by 
Eller on depressed people in 2008 and 2009. In these studies, people 
underwent various antidepressant treatments and there was only a 
decrease in the depression score, but no changes were observed in 
the TNF-α level30,31. Jazayeri (2010) studied the changes in HPA axis 
and cytokines after administration of fluoxetine on depressed people 
and analyzed the cortisol serum level, IL-6 and IL-1β. No changes 
were observed in the level of cytokines, but there was a significant 
decrease in the cortisol level after treatment32. In a study done by 
Pan et al., in which Icariin was used as an antidepressant, the TNF-α 
level showed a negative growth in some doses of the drug (75 mg) 
that had caused a decrease in the cortisol serum levels. On the other 
hand, no changes were observed in the TNF-α levels or cortisol level 
in lower doses of the drug (35 mg). Accordingly, if antidepressants 
lead to effective successful treatment and a decrease in the cortisol 
level, there will be an increase in TNF-α33. 
Table 3. Depression score, serum levels of TNF-α and cortisol level changes in both groups before and after intervention
Depression1
Mean (SD)
Depression2
Mean (SD)
P
Fluoxetine (n = 27) 24.95 (7.98) 18.52 (9.63) p < 0.001
Control (n = 28) 22.16 (8.69) 19.70 (7.52) 0.274
TNF-α1
Mean (SD)
TNF-α2
Mean (SD)
Fluoxetine (n = 27) 71.98 (6.22) 360.17 (47.86) p < 0.001
Control (n = 28) 85.32 (7.28) 109.49 (32.58) 0.106
Cortisol1
Mean (SD)
Cortisol2
Mean (SD)
Fluoxetine (n = 27) 24.89 (9.98) 16.17 (6.32) 0.001
Control (n = 28) 18.23 (8.09) 17.65 (8.37) 0.734
Depression1, TNF-α 1, Cortisol1: before intervention.
Depression2, TNF-α 2, Cortisol2: after intervention on the day of embryo transfer to the uterus.
Table 4. Difference between oocytes taken and pregnancy rate in two groups
Pregnant, N (%) Not pregnant, N (%) P Number of
Oocyte
Mean (SD)
P
Fluoxetine (n = 27) 7 (25.92) 20 (74.07) 0.04 16.04 (7.97) 0.160
Control (n = 28) 3 (10.71) 25 (92.59) 13.0 (6.36)
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There are 3 hypotheses on the effect of TNF-α on oocytes: 1. 
TNF-α affects the oocyte during its maturation and causes disorders 
in cleavage stage; 2. TNF-α on the embryo after fertilization 
prevents it from growing and turning into blastocyst; and 3. TNF-α 
increases chances of apoptosis in blastomeres34. According to these 
hypotheses, TNF-α may not affect the number of oocytes and embryo 
implantation, but it increases the chances of early destruction of 
the embryo and miscarriage. According to a study done by Soto 
(2003) on the effect of TNF-α on fertility in cattle, TNF-α caused an 
increase in apoptosis and destruction of the embryo at the beginning 
of pregnancy although it had no effect on the oocyte maturation and 
fertilization34. In the present study, there was no significant difference 
in the two groups as to the number of oocytes, and an increase 
in TNF-α did not affect the number of oocytes either. According 
to a study done by Brogin Moreli (2012), the effect of TNF-α is 
shown through its impact on cell proliferation, differentiation and 
apoptosis in the tissue and disorders in these would lead to early 
loss of the fetus35. In other words, if faced with TNF-α, there may 
be no difference in the number of oocytes and positive pregnancy 
test among the people. However, the embryo does have the ability 
to replicate and grow well after pregnancy, which could lead to 
early loss of pregnancy. In the present study, the two groups were 
also compared in terms of pregnancy. Accordingly, the number of 
pregnancies in the Fluoxetine group was twice as many as that in 
the control group and also an increase in TNF-α did not affect the 
pregnancy rate. Unlike our results, the findings of the studies done 
by Xu et al. (2018) and Boudjenah et al. (2014) showed that an 
increase in the TNF-α serum levels caused disorders in the embryo 
implantation, as a result of which there was a decrease in pregnancy 
rate during IVF36,37. According to Lee et al., an increase in the TNF-α 
level decreases the quality, but not the number of oocytes and there 
is no relationship between its level and pregnancy8. 
On the other hand, it could be concluded that a decrease in 
cortisol increased the pregnancy rate because the results of the 
studies done on this field have shown that cortisol changes the 
immunological conditions of the uterus and prevents the embryo 
implantation12,38. According to a study done by An et al. (2013), 
low levels of this hormone on the egg harvesting day increased the 
chances of the patients’ pregnancy38. However, according to a study 
done by Csemiczky et al. (2000), there was no difference between 
pregnant and non-pregnant women in the cortisol level39.
Conclusion
The findings of the study showed that there was a significant decrease 
in the depression score of the intervention group as a result of taking 
fluoxetine. There was also a decrease in the cortisol serum levels that 
caused an increase in TNF-α due to the effect of negative feedback. 
However, an increase in the serum level of this cytokine did not have 
a negative effect on the number of oocytes and patients’ pregnancy. 
The reason behind it could be the effect of this cytokine on the 
embryo opoptosis and an increase in the chances of miscarriage, not 
a decrease in pregnancy. On the other hand, a decrease in cortisol 
in the fluoxetine group provided the immunological conditions of 
the uterus for pregnancy and there was a significant increase in the 
number of pregnancies in the intervention group. There was no 
difference between the groups in terms of the number of harvested 
oocytes. We recommend that there should be an increase in the 
number of samples in future studies so that we can analyze the results 
more precisely and reach more certain conclusions. 
Strengths and limitations
The most important limitation of this study was the small of number 
of depressed infertile patients that were willing to participate. 
Because of cultural, mental and family conditions, this group does 
not usually tend to take medicines, except for those related to IVF 
cycles, which led to a lot of limitations on our study. We recommend 
hperforming more precise and certain analysies through more 
sampling of these specific cases. Moreover, because of the TNF-α’s 
effects on increasing the rate of miscarriage, we suggest increasing 
the follow-up procedures in these patients to also evaluate this rate 
in future studies.
The strength of this study lies in the simultaneous analysis of 
the changes in the HPA axis through cortisol, changes in TNF-α 
cytokine after the intervention, and treating patients and continuing 
the follow-ups until they get fertile. However, the above-mentioned 
points have rarely been analyzed simultaneously in other studies. 
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